Coronary Artery Disease, Coronary Disease
Conditions
Keywords
Xience Sierra, Drug Eluting Stent, Percutaneous coronary intervention
Brief summary
The objective of this study is to evaluate effectiveness and safety of Xience Sierra stent in the real world daily practice as compared with other drug-eluting stents.
Interventions
DEVICEXience Sierra stent
Percutaneous coronary intervention with Xience Sierra stent
Sponsors
CardioVascular Research Foundation, Korea
Seung-Jung Park
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 19 and more * Patient with Xience Sierra Everolimus eluting coronary stent * Written consent
Exclusion criteria
* Intervention with Xience Sierra Everolimus eluting coronary stent and other drug eluting stent at the same time * Life-expectancy less than 1 year * Cardiac shock
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR) | 1 year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cardiac death | 5 year | — |
| Myocardial Infarction | 5 year | — |
| Composite event rate of death or myocardial infarction (MI) | 5 year | — |
| Composite event rate of cardiac death or myocardial infarction (MI) | 5 year | — |
| All cause death | 5 year | — |
| Target- Lesion Revascularization | 5 year | — |
| Stent thrombosis | 5 year | — |
| Stroke | 5 year | — |
| Procedural Success rate | 5 year | Procedural success rate is defined as \< 30 % final stenosis and the absence of in-hospital event including death, myocardial infarction, repeat revascularization. |
| Target- Vessel Revascularization | 5 year | — |
Countries
South Korea
Outcome results
None listed